Don Karl Juravin and April Goodwin - Adversary Proceeding

CourtUnited States Bankruptcy Court, M.D. Florida
DecidedOctober 27, 2020
Docket6:19-ap-00030
StatusUnknown

This text of Don Karl Juravin and April Goodwin - Adversary Proceeding (Don Karl Juravin and April Goodwin - Adversary Proceeding) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Don Karl Juravin and April Goodwin - Adversary Proceeding, (Fla. 2020).

Opinion

ORDERED. Dated: October 27, 2020 ) Warn area S_. Jennemann United States Bankrupt nde

UNITED STATES BANKRUPTCY COURT MIDDLE DISTRICT OF FLORIDA ORLANDO DIVISION www.flmb.uscourts.gov In re ) ) Don Karl Juravin, ) Case No. 6:18-bk-06821-KSJ ) Chapter 7 Debtor. ) ——eses—“‘(‘_éCOD ) Federal Trade Commission, ) ) ) ) Plaintiff, ) ) VS. ) Adversary No. 6:19-ap-00030-KSJ ) Don Karl Juravin, ) ) Defendant. ) ee) MEMORANDUM OPINION FINDING DEBT NOT DISCHARGEABLE Plaintiff, the Federal Trade Commission (“FTC”), asserts its $25 million judgment against the Debtor, Don Karl Juravin, is not dischargeable under 11 U.S.C. § 523(a)(2)(A) of the Bankruptcy Code.! The Court already has issued a partial summary judgment? resolving all issues

' All references to the Bankruptcy Code refer to 11 U.S.C. § 101, et. seq. 2 Doc. No. 34.

for the Plaintiff except one remaining dispute—whether the Debtor, by making numerous affirmative misrepresentations about the efficacy of his weight-loss products, acted with the “intent to deceive” his customers. After listening to the Debtor’s unpersuasive explanation at trial,3 I find the Debtor intended to deceive his customers to enrich himself by over $7 million. Debtor did not

enrich himself for any altruistic purpose. Plaintiff’s judgment against the Debtor is not discharged. Before filing this bankruptcy case, the Debtor owned Must Cure Obesity, Co.4 and Juravin, Incorporated and was an officer of Roca Labs, Inc., Roca Labs Nutraceutical USA, Inc., and Zero Calorie Labs, Inc. (collectively, the “Roca Entities”). Defendant operated the Roca Entities from 2009-2016. He received at least $7 million from the enterprise. Defendant sold weight-loss products, including Roca Labs Formula and Roca Labs Anti- Cravings, as a safe and cost-effective alternative to gastric bypass surgery to combat obesity and achieve substantial weight-loss (the “Products”). Consumers paid hundreds of dollars for the Products, which were worthless other than to convince customers they were following a fake medical regime to lose weight. During testimony, Debtor conceded the only way his customers

lost weight was to eat less and exercise more, something they could do without buying his expensive Products. The FTC sued Debtor and the Roca Entities in the United States District Court for the Middle District of Florida (“District Court”) alleging claims of deceptive trade practices under

3 Debtor requested a translator to assist him with his testimony. See Doc. No. 38. The Court granted this request. Doc. No. 45. The translator assisted the Debtor throughout the trial, however, due to her illness, the trial, scheduled to start on June 25, 2020, was continued until August 17 and 18, 2020. The Court received testimony from two third-party witnesses on June 26, 2020—Dr. Marcus Free and Tejas Chokis. Debtor testified on August 17 and 18, 2020. Both parties submitted post-trial closing arguments. Doc. Nos. 80, 81, and 84. Parties also designated deposition testimony excerpts. Doc. Nos. 51, 52, and 61. 4 Must Cure Obesity, Co. filed a petition seeking relief under Chapter 11 of the Bankruptcy Code on January 31, 2020. Case No. 8:20-bk-00924-CED. The case quickly was dismissed because the Debtor failed to pay the filing fee or file needed papers. Doc. No. 13. The case has been closed since March 24, 2020. Sections 5(a) and 12 of the Federal Trade Commission Act (“FTC Act”).5 The District Court granted summary judgment for the FTC and later entered a separate judgment awarding damages of $25,246,000 against the Debtor (the “Judgment”).6 No trial was held; the District Court did not receive testimony or make any findings of the Debtor’s credibility. Juravin then filed this Chapter 7 bankruptcy case.7 The FTC filed this adversary proceeding

seeking a determination that the Judgment is excepted from discharge under § 523(a)(2)(A) of the Bankruptcy Code and sought summary judgment.8 Debtor conceded summary judgment was proper except for one remaining issue—whether the Debtor acted with the “intent to deceive,” which was not decided by the District Court.9 Partial summary judgment was granted, and the trial was scheduled. Under Section 523(a)(2)(A) of the Bankruptcy Code, a debtor cannot discharge a debt based on “false pretenses, a false representation, or actual fraud, other than a statement respecting the debtor's or an insider's financial condition.”10 “Courts have generally interpreted § 523(a)(2)(A) to require the traditional elements of common law fraud.”11 To prove fraud, the

plaintiff must establish these elements by a preponderance of the evidence: (i) the debtor made a

5 See Federal Trade Commission v. Roca Labs, Inc., 345 F.Supp.3d 1375 (M.D. Fla. 2018) for a full discussion of the District Court case. The opinion explains in detail the numerous deceptive and false statements made by the Debtor and the Roca Entities in selling their weight-loss Products. 6 Roca Labs, 345 F.Supp.3d 1375. On September 14, 2018, the District Court granted the FTC’s Motion for Summary Judgment on the Section 5(a) and 12 claims and on January 4, 2019, entered the Judgment against the Debtor and five Roca Labs-related corporate defendants, jointly and severally. See Doc. No. 1, Exh. A. 7 Doc. No. 1, Case No. 6:18-bk-06821-KSJ. The Chapter 7 liquidation case was filed on October 31, 2018. The bankruptcy case was converted to a Chapter 11 reorganization case on September 16, 2019, after this adversary proceeding was filed. Because the Debtor was unable to confirm a Chapter 11 Plan, the case reconverted to a Chapter 7 liquidation case on March 16, 2020. Doc. No. 323, Case No. 6:18-bk-06821-KSJ. Because no other creditor objected, the Debtor received a Discharge of all other debts on June 26, 2020. Doc. No. 368, Case No. 6:18-bk-06821-KSJ. 8 Doc. No. 15. Plaintiff also filed a Statement of Undisputed Facts in Support of Motion for Summary Judgment, and a Memorandum in Support of Summary Judgment. Doc. Nos. 16 and 17. Defendant filed a Response to Plaintiff’s Motion for Summary Judgment and Memorandum of Law in Opposition. Doc. No. 22. Plaintiff filed a Reply and Memorandum in Support of Motion for Summary Judgment. Doc. No. 29. 9 Doc. No. 22. 10 11 U.S.C. § 523(a)(2)(A). 11 See SEC v. Bilzerian (In re Bilzerian), 153 F.3d 1278, 1281 (11th Cir. 1998). false representation with intent to deceive the creditor; (ii) the creditor relied on the misrepresentation; (iii) the reliance was justified; and (iv) the creditor sustained a loss because of the misrepresentation.12 All of these elements except “intent to deceive” was decided on summary judgment.13

Free access — add to your briefcase to read the full text and ask questions with AI

Related

SEC v. Bilzerian
153 F.3d 1278 (Eleventh Circuit, 1998)
Grogan v. Garner
498 U.S. 279 (Supreme Court, 1991)
Conseco v. Howard (In Re Howard)
261 B.R. 513 (M.D. Florida, 2001)
Fed. Trade Comm'n v. Roca Labs, Inc.
345 F. Supp. 3d 1375 (M.D. Florida, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Don Karl Juravin and April Goodwin - Adversary Proceeding, Counsel Stack Legal Research, https://law.counselstack.com/opinion/don-karl-juravin-and-april-goodwin-adversary-proceeding-flmb-2020.